End stage renal disease. End-stage renal disease
Conditions
Interventions
Intervention 1: Gentamicin 0.1% ointment daily on the catheter exit site of peritoneal dialysis for 6 months. Intervention 2: Mupirocine 2% ointment daily on the catheter exit site of peritoneal dialy
Treatment - Drugs
Gentamicin 0.1% ointment daily on the catheter exit site of peritoneal dialysis for 6 months
Mupirocine 2% ointment daily on the catheter exit site of peritoneal dialysis for 6 months
Sponsors
Vice Chancellor for Research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age at least 18 years, at least 3 months on peritoneal dialysis, Satisfaction to participate in the study, lack of cutaneous hypersensitivity to gentamicin or Mupirocine ointments, Not receiving systemic antibiotics during the 30 days prior to the study Exclusion criteria: systemic antibiotic treatment during the study, changing in dialysis route, transplantation or death, no satisfaction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of peritonitis. Timepoint: monthly. Method of measurement: clinical symptoms and direct inspection of dialysis fluid. | — |
Secondary
| Measure | Time frame |
|---|---|
| Raete of exit site infection. Timepoint: monthly. Method of measurement: clinical symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mojgan Mortazavi
Isfahan University of Medical Sciences
Outcome results
None listed